Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Respirology (Carlton, Vic.)|October 6, 2010
Alveolar proteinosis with hypersensitivity pneumonitis: a new clinical phenotypeHema Verma, Andrew G Nicholson, Keith M Kerr, et al.
The European Respiratory Journal|March 24, 2012
Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypesTaryn L Reddy, Masaki Tominaga, David M Hansell, et al.
Gastroenterology|July 13, 2010
A 4-gene signature predicts survival of patients with resected adenocarcinoma of the esophagus, junction, and gastric cardiaChristopher J Peters, Jonathan R E Rees, Richard H Hardwick, et al.
Thorax|July 26, 2020
Inhibition of mast cells: a novel mechanism by which nintedanib may elicit anti-fibrotic effectsCatherine Overed-Sayer, Elena Miranda, Rebecca Dunmore, et al.
Thorax|September 5, 2020
Lesson of the month: novel method to quantify neutrophil uptake in early lung cancer using SPECT-CTNeda Farahi, Daniel Gillett, Mark Southwood, et al.
Scientific Reports|November 4, 2021
Sensitization of the UPR by loss of PPP1R15A promotes fibrosis and senescence in IPFSusan Monkley, Catherine Overed-Sayer, Helen Parfrey, et al.
Oncogene|July 14, 2020
Targeting the MAPK7/MMP9 axis for metastasis in primary bone cancerDarrell Green, Heather Eyre, Archana Singh, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 23, 2013
The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantationGerald J Berry, Margaret M Burke, Claus Andersen, et al.
The Lancet. Respiratory Medicine|November 19, 2017
An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort studyToby M Maher, Eunice Oballa, Juliet K Simpson, et al.
Biorxiv : the Preprint Server for Biology|October 27, 2020
Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severityLinh T Bui, Nichelle I Winters, Mei-I Chung, et al.
Pageof 4